| NASDAQ (usa) |
|
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
| DAX (german) |
|
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
HLS Therapeutics Inc (PINK: HLTRF)
HLTRF Technical Analysis
3
| As on 1st Jan 2026 HLTRF STOCK Price closed @ 3.43 and we RECOMMEND Buy for LONG-TERM with Stoploss of 0.21 & Buy for SHORT-TERM with Stoploss of 0.91 we also expect STOCK to react on Following IMPORTANT LEVELS. |
HLTRFSTOCK Price
| Open | 3.45 | Change | Price | % |
| High | 3.45 | 1 Day | -0.59 | -14.68 |
| Low | 3.43 | 1 Week | 0.47 | 15.88 |
| Close | 3.43 | 1 Month | 0.92 | 36.65 |
| Volume | 600 | 1 Year | 0.92 | 36.65 |
| 52 Week High 4.02 | 52 Week Low 2.51 | ||||
PINK USA Most Active Stocks
| ECOX | 0.00 | % |
| VNUE | 0.00 | % |
| GTVH | 0.00 | % |
| EARI | 0.00 | % |
| AURI | 0.00 | % |
| GGSM | 0.00 | % |
| TRSI | 0.00 | % |
| HMBL | 0.00 | % |
| TXGE | 3316.21 | 2.69% |
| KEGS | 0.00 | % |
PINK USA Top Gainers Stocks
PINK USA Top Losers Stocks
| HLTRF Daily Charts |
HLTRF Intraday Charts |
Whats New @ Bazaartrend |
HLTRF Free Analysis |
|
|
HLTRF Important Levels Intraday
| RESISTANCE | 3.47 |
| RESISTANCE | 3.46 |
| RESISTANCE | 3.45 |
| RESISTANCE | 3.44 |
| SUPPORT | 3.42 |
| SUPPORT | 3.41 |
| SUPPORT | 3.40 |
| SUPPORT | 3.39 |
HLTRF Forecast March 2026
| 4th UP Forecast | 6.34 |
| 3rd UP Forecast | 5.41 |
| 2nd UP Forecast | 4.83 |
| 1st UP Forecast | 4.25 |
| 1st DOWN Forecast | 2.61 |
| 2nd DOWN Forecast | 2.03 |
| 3rd DOWN Forecast | 1.45 |
| 4th DOWN Forecast | 0.52 |
HLTRF Weekly Forecast
| 4th UP Forecast | 5.11 |
| 3rd UP Forecast | 4.57 |
| 2nd UP Forecast | 4.24 |
| 1st UP Forecast | 3.90 |
| 1st DOWN Forecast | 2.96 |
| 2nd DOWN Forecast | 2.62 |
| 3rd DOWN Forecast | 2.29 |
| 4th DOWN Forecast | 1.75 |
HLTRF Forecast2026
| 4th UP Forecast | 6.34 |
| 3rd UP Forecast | 5.41 |
| 2nd UP Forecast | 4.83 |
| 1st UP Forecast | 4.25 |
| 1st DOWN Forecast | 2.61 |
| 2nd DOWN Forecast | 2.03 |
| 3rd DOWN Forecast | 1.45 |
| 4th DOWN Forecast | 0.52 |
HLS Therapeutics Inc ( PINK USA Symbol : HLTRF )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
HLTRF Other Details
| Segment | EQ | |
| Market Capital | 503208128.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > echo $website ; ?> | |
HLTRF Address
![]() |
||
HLTRF Latest News
HLTRF Business Profile
HLS Therapeutics Inc., a specialty pharmaceutical company, acquires and commercializes pharmaceutical products in the specialty central nervous system and cardiovascular markets in Canada, the United States, and internationally. Its lead product is Clozaril, an atypical antipsychotic used in the treatment of schizophrenia. The company also holds the U.S. marketing rights of Absorica, a commercial stage dermatology product. HLS Therapeutics Inc. has a license agreement with Amarin Corporation plc to register, commercialize, and distribute Vascepa capsules in Canada. The company was founded in 2018 and is headquartered in Toronto, Canada. Address: 10 Carlson Court, Toronto, ON, Canada, M9W 6L2
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service

